Prevalence of Microscopic Colitis in Diarrhea-predominant Irittable Bowel Syndrome Patients Cohort Study From Upper Egypt

被引:1
作者
Ebeid, Basel [1 ]
Eid, Ragaey A. [1 ]
Attia, Dina [1 ]
Daoud, Sahar A. [2 ]
Tawfik, Mohammad M. [1 ]
Fattah, Ali M. Abdel [1 ]
机构
[1] Beni Suef Univ, Dept Gastroenterol Hepatol & Endem Med, Fac Med, Mokbel St, Bani Suwayf 62511, Egypt
[2] Beni Suef Univ, Fac Med, Dept Pathol, Bani Suwayf, Egypt
关键词
diarrhea-predominant IBS; colonic mucosa; microscopic colitis; SYNDROME-LIKE SYMPTOMS; ULCERATIVE-COLITIS; CELIAC-DISEASE; DIAGNOSIS; RISK; CRITERIA;
D O I
10.1097/MCG.0000000000001592
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: There is controversy about colonoscopy and taking biopsy from the normal colonic mucosa in patients with a clinical diagnosis of diarrhea-predominant irritable bowel syndrome (D-IBS). This study aims to estimate the prevalence of microscopic colitis (MC) in D-IBS patients and to select patients without the well-known alarming features who will benefit from colonoscopy and biopsies from the normal colonic mucosa. Patients and Methods: We performed a cohort cross-sectional study over 6 months duration in a total of 129 patients with Rome III criteria of D-IBS after excluding cases with features of organic diseases. Cases were subjected to colonoscopy and biopsies from the colonic mucosa that seemed normal. Results: Histopathologic examination of biopsies taken from cases with normal colonic mucosa revealed 86 (71.66%) cases with nonspecific colitis, 26 (21.66%) cases with MC and 8 (6.66%) cases with ulcerative colitis. Concomitant immunologic diseases (P=0.00005) and triggering drugs intake (P=0.006) were significantly more common in the MC group. The mean duration of diarrhea in MC patients was significantly longer than that of nonspecific colitis and ulcerative colitis patients (P=0.0006). Conclusions: Prevalence of MC in D-IBS patients from Upper Egypt is relatively high (21.66%). Concomitant immunologic diseases, possible triggering drugs intake, and long duration of diarrhea are significant risk factors for undiagnosed MC in D-IBS patients.
引用
收藏
页码:E232 / E238
页数:7
相关论文
共 33 条
  • [21] Small intestinal bacterial overgrowth as an uncommon cause of false positive lactose hydrogen breath test among patients with diarrhea-predominant irritable bowel syndrome in Asia
    Wang, Yilin
    Xiong, Lishou
    Gong, Xiaorong
    Li, Weimin
    Zhang, Xiangsong
    Chen, Minhu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (06) : 995 - 1000
  • [22] Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial
    Liang, Shi-Bing
    Han, Mei
    Cheng, Hong-Jie
    Zhang, Qiao-Yan
    Zhang, Nai-Wei
    Jia, Bo-Yi
    Robinson, Nicola
    Liu, Jian-Ping
    TRIALS, 2022, 23 (01)
  • [23] Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1
    Shiotani, A.
    Kusunoki, H.
    Ishii, M.
    Imamura, H.
    Manabe, N.
    Kamada, T.
    Hata, J.
    Merchant, J. L.
    Haruma, K.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (01) : 82 - 91
  • [24] The Short-Term Efficacy of Bifidobacterium Quadruple Viable Tablet in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Potentially Mediated by Metabolism Rather Than Diversity Regulation
    Bai, Tao
    Xu, Zhiyue
    Xia, Peijun
    Feng, Yichao
    Liu, Bing
    Liu, Hongling
    Chen, Yunwang
    Yan, Guangjun
    Lv, Bin
    Yan, Zaihong
    Dai, Ning
    Long, Yanqin
    Wei, Wei
    Shi, Zhihong
    Li, Xiaoqing
    Fang, Xiucai
    Gao, Huibin
    Qi, Lingzhi
    Hou, Xiaohua
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (07) : 1256 - 1267
  • [25] Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial
    Shin, Seung Yong
    Park, Sein
    Moon, Jung Min
    Kim, Kisung
    Kim, Jeong Wook
    Chun, Jongsik
    Lee, Tae Hee
    Choi, Chang Hwan
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (04) : 642 - 654
  • [26] Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1™) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
    Jung, Kyoungmi
    Kim, Areum
    Lee, Ji-Hae
    Cho, Donghyun
    Seo, Juyeon
    Jung, Eun Sung
    Kang, Hye-ji
    Roh, Jonghwa
    Kim, Wangi
    NUTRIENTS, 2022, 14 (10)
  • [27] Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study
    Fukuba, Nobuhiko
    Ishihara, Shunji
    Tada, Yasumasa
    Oshima, Naoki
    Moriyama, Ichiro
    Yuki, Takafumi
    Kawashima, Kousaku
    Kushiyama, Yoshinori
    Fujishiro, Hirofumi
    Kinoshita, Yoshikazu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 674 - 680
  • [28] Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6-A Randomized Clinical Trial
    Sikaroudi, Masoumeh Khalighi
    Mokhtare, Marjan
    Janani, Leila
    Kashani, Amir Hossein Faghihi
    Masoodi, Mohsen
    Agah, Shahram
    Abbaspour, Narjes
    Dehnad, Afsaneh
    Shidfar, Farzad
    COMPLEMENTARY MEDICINE RESEARCH, 2020, 27 (05) : 302 - 309
  • [29] Irritable bowel syndrome-like symptoms in treated microscopic colitis patients compared with controls: a cross-sectional study
    Pagoldh, Jenny
    Lundgren, David
    Suhr, Ole B.
    Karling, Pontus
    GASTROENTEROLOGY REPORT, 2020, 8 (05): : 374 - 380
  • [30] Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    Tomita, Toshihiko
    Fukui, Hirokazu
    Morishita, Daisuke
    Mori, Sumire
    Oshima, Tadayuki
    Shinzaki, Shinichiro
    Miwa, Hiroto
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)